Colorado biotech plans $200 million stock offering
A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock.
Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares.
"We intend to use the net proceeds from this offering to fund our research and development efforts, including c linical trials for our proprietary candidates, build and scale commercial capability, and for general…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Ben Miller Source Type: news
More News: Biotechnology | Health Management